Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.50 |
| ▸ | CA1 | P00915 | 10/20 | 0.50 |
| ▸ | CA9 | Q16790 | 8/20 | 0.50 |
| ▸ | CA12 | O43570 | 5/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | BCL2 | P10415 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 3/20 | 0.47 |
| ▸ | CA5A | P35218 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30988956 | 1.00 | CA2 (0.50) | CA2CA1CA9CA12CA14 | |
| Methane SCHEMBL28850761 | 0.98 | CA2 (0.49) | CA2CA1CA9CA12CA14 | |
| Hydrochloric Acid SCHEMBL3517386 | 0.98 | CA1 (0.49) | CA2CA1CA9CA12CA14 | |
| SCHEMBL4662843 | 0.85 | PTGES2 (0.54) | CA2CA1CA9CA12CA14 | |
| SCHEMBL4664432 | 0.85 | CA1 (0.42) | CA2CA1CA9CA12CA14 | |
| SCHEMBL6121437 | 0.85 | CA1 (0.45) | CA2CA1CA9CA12CA14 | |
| SCHEMBL4662891 | 0.85 | CA2 (0.47) | CA2CA1CA9CA12CA14 | |
| SCHEMBL4183580 | 0.85 | CA1 (0.45) | CA2CA1CA9CA12CA14 | |
| SCHEMBL4662818 | 0.85 | CA2 (0.47) | CA2CA1CA9CA12CA14 | |
| SCHEMBL4663042 | 0.85 | KCNA5 (0.43) | CA2CA1CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108409612-A | A kind of method that N- benzyl benzenesulfonamides are catalyzed and synthesized by boric acid/Catalyzed by Oxalic Acid system under microwave radiation | 福建医科大学 | 2018-08-17 | — | — | CN | claimed |
| US-20080166359-A1 | Methods of using MEK inhibitors | EXELIXIS, INC. | 2008-07-10 | — | — | US | claimed |
| EP-4716529-A2 | COMPOUNDS THAT RE-ACTIVATE MUTANT P53 | Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center (US) | 2026-04-01 | — | — | EP | disclosed |
| WO-2024243343-A2 | COMPOUNDS THAT RE-ACTIVATE MUTANT P53 | KARANICOLAS JOHN (US) | 2024-11-28 | — | — | WO | disclosed |
| US-11339122-B2 | hTRPV1 chemical agents | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2022-05-24 | — | — | US | disclosed |
| US-11124482-B2 | C-met modulators and methods of use | EXELIXIS, INC. (US) | 2021-09-21 | — | — | US | disclosed |
| US-20210253530-A9 | C-MET MODULATORS AND METHODS OF USE | EXELIXIS, INC. | 2021-08-19 | — | — | US | disclosed |
| US-20210171454-A1 | hTRPV1 CHEMICAL AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-06-10 | — | — | US | disclosed |
| US-10899702-B2 | HTRPVI chemical agents | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2021-01-26 | — | — | US | disclosed |
| US-20200331860-A1 | C-Met Modulators and Methods of Use | EXELIXIS INC (US) | 2020-10-22 | — | — | US | disclosed |
| CN-107739322-B | Synthetic method of sulfonamide compound | 济南大学 | 2020-06-23 | — | — | CN | disclosed |
| WO-2000047568-A2 | 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES | G.D. SEARLE LLC (US) | 2000-08-17 | — | — | WO | disclosed |
| EP-0468971-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1992-02-05 | — | — | EP | disclosed |
| US-4629810-A | HERBICIDES | CIBA-GEIGY CORPORATION (US) | 1986-12-16 | — | — | US | disclosed |
| US-4510325-A | Phenyl sulfonamides | CIBA-GEIGY CORPORATION (US) | 1985-04-09 | — | — | US | disclosed |
| US-4479821-A | HERBICIDES, PLANT GROWTH REGULATORS | CIBA-GEIGY CORPORATION (US) | 1984-10-30 | — | — | US | disclosed |
| US-4468245-A | N-(2,3-Epoxypropylene)-n-aralkylsulfonamide and herbicidal compositions containing the same | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) | 1984-08-28 | — | — | US | disclosed |
| US-4443245-A | HERBICIDES, PLANT GROWTH REGULATORS | CIBA-GEIGY CORPORATION (US) | 1984-04-17 | — | — | US | disclosed |
| US-4425154-A | HERBICIDES, PLANT GROWTH REGULATORS | CIBA-GEIGY CORPORATION (US) | 1984-01-10 | — | — | US | disclosed |
| US-4419121-A | HERBICIDES | CIBA-GEIGY CORPORATION (US) | 1983-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331860-A1 | C-Met Modulators and Methods of Use | FLT4, FLT1, MET | CA2 1724/4885CA1 3329/4885CA9 1962/4885 |
| US-10899702-B2 | HTRPVI chemical agents | TRPV1, TRPA1, TRPV3 | CA2 639/4885CA1 2144/4885CA9 3186/4885 |
| US-20210171454-A1 | hTRPV1 CHEMICAL AGENTS | TRPV1, TRPA1, TRPV4 | CA2 680/4885CA1 2152/4885CA9 3490/4885 |
| US-20210253530-A9 | C-MET MODULATORS AND METHODS OF USE | FLT4, FLT1, MET | CA2 1724/4885CA1 3329/4885CA9 1962/4885 |
| US-20080166359-A1 | Methods of using MEK inhibitors | BRAF, NRAS, KRAS | CA2 735/4885CA1 1855/4885CA9 750/4885 |
| US-11124482-B2 | C-met modulators and methods of use | FLT4, FLT1, MET | CA2 1724/4885CA1 3329/4885CA9 1962/4885 |
| US-11339122-B2 | hTRPV1 chemical agents | TRPV1, TRPA1, TRPV4 | CA2 726/4885CA1 2251/4885CA9 3519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.